Neelim للاستشارات الصحية
Neelim
Consultant title · oral assessment

Consultant Gastroenterology oral assessment prep

14 panel-style scenarios with model answers structured in the three graded domains - knowledge, management, and ethics & communication.

Pass / fail panel14 scenarios
AED 699one-time
About 68% of one exam fee
Request this question bank

Tell us your authority and we send the bank for that exam, usually the same day.

What is riding on this exam

~AED 1,030
DHA exam fee, per attempt
Paid again on every re-sit. Other regulators' fees are in the table below.
3
UAE attempts - in total
Shared across DHA, DOH, MOHAP and SHA, not three each. Saudi, Qatar, Oman and Kuwait rules are in the FAQ.
Pass / fail
Panel decision
Judged by the panel, not a percentage. Formats differ by authority.

One failed attempt costs you the fee again, plus months of delay on your licence, your visa and your start date. This pack costs about 68% of one exam fee.

Every regulator: format, pass marks and fees for all GCC licensing exams, each from the regulator's own documents.

Try a scenario from this pack

An original scenario, written the way a panel would put it to you.

Scenario 1Gastrointestinal Bleeding / Portal Hypertension

You are the on-call consultant gastroenterologist in a tertiary hospital at 02:00. A 55-year-old man with known hepatitis C cirrhosis, Child-Pugh C (score 10), is brought to the emergency department having vomited approximately one litre of fresh blood at home. His blood pressure is 82/48 mmHg, heart rate 122, he is drowsy but rousable, haemoglobin 71 g/L, platelets 62, INR 2.1, bilirubin 78 micromol/L and creatinine 148 micromol/L. The emergency physician has started crystalloid and is asking whether to transfuse four units of packed cells and correct the INR with fresh frozen plasma before calling you to scope. How would you manage this patient?

What the panel is assessing

The panel is testing whether the candidate can lead a time-critical resuscitation in a decompensated cirrhotic, apply a restrictive transfusion strategy and modern coagulation understanding rather than reflex product transfusion, and sequence airway, drugs, antibiotics, endoscopy and pre-emptive TIPS correctly. It also probes whether the candidate can direct a multidisciplinary team under pressure rather than simply describe endoscopic technique.

Liked those? The full pack has 14 scenarios at this standard - every one with a model answer.

Get the full pack - AED 699

What's inside

  • ✓14 original panel-style scenarios
  • ✓Model answer in all three graded domains
  • ✓Likely panel follow-up probes
  • ✓The pitfalls that fail candidates
  • ✓4+ ethics, consent and error-disclosure cases
  • ✓How each authority runs its oral

How the consultant Gastroenterology oral is run, by authority

Consultant applicants who are not exempt are usually assessed by a panel rather than a computer exam. The format differs by authority.

AuthorityFormatLengthPanel and result
DHA - DubaiNot less than five clinical scenarios in your specialtyRoughly 20-30 minutesAt least two panellists, one pass or fail decision
DOH - Abu Dhabi5-6 case scenarios, including an ethical case45-60 minutesHeld on Microsoft Teams
SCFHS - Saudi ArabiaStructured consultant interview built on clinical casesTwo sessions of roughly 30 minutesSenior consultants in your specialty
OMSB - OmanViva on specialty cases, taken after the written examNot publishedRequired of every candidate

QCHP and NHRA assess most applicants by written exam and may add an interview or clinical assessment case by case. Your own eligibility notice is the final word on your route.

What a Gastroenterology panel is assessing

Scenarios are judged across three domains: clinical knowledge, management, and ethics and communication. In Gastroenterology, that looks like this:

  • •The panel is testing absolute clarity on the legal and ethical primacy of a competent adult's refusal, including through subsequent unconsciousness, together with a genuine command of bloodless haemorrhage management so that respecting autonomy does not become therapeutic nihilism.
  • •The panel is testing precise knowledge of HBV reactivation risk stratification and prophylaxis, and equally the professional skill of holding a correct position against a senior colleague from another specialty without obstructing the patient's cancer treatment.
  • •The panel is testing intraprocedural crisis management and closure technique, but principally whether the candidate will conduct a full, prompt, honest open disclosure without defensiveness, report the incident, and reflect on the systems factors that contributed rather than blaming the trainee or the patient's anatomy.

How to structure an oral answer

  1. 1Say what it is and why it is dangerous. Open with the working diagnosis, the one or two alternatives you must exclude, and what will harm the patient first.
  2. 2Show the knowledge that changes the decision. Name the finding, test or trial result your plan rests on. Panels mark reasoning, not recitation.
  3. 3Manage in time order. What you do in the next ten minutes, the next hour and the next day, who you escalate to, and what would make you change course.
  4. 4Close on ethics and communication. Consent or capacity, the family conversation, disclosure if something went wrong, and what you document. Every authority examines this domain.

Worked Gastroenterology scenario outlines

4 original scenarios from the pack, written the way a panel would put them to you. Each outline shows the opening of the model answer in all three domains, the follow-up questions to expect and the mistakes that fail candidates.

Decompensated Cirrhosis, Hepatorenal Syndrome and End-of-Life Care

A 61-year-old man with alcohol-related cirrhosis, Child-Pugh C and MELD-Na 31, has been readmitted for the fifth time in six months with tense refractory ascites requiring large-volume paracentesis every ten days. Creatinine has risen from 96 to 236 micromol/L over five days despite diuretic withdrawal, sodium is 124 mmol/L, urine sodium is low and urinalysis is bland; ascitic fluid shows 90 neutrophils per mm3. He has been declined for transplantation because of ongoing alcohol use and frailty, and he asks you whether he is dying and whether there is anything more you can do. How do you manage him?

What the panel is testing: This tests the diagnosis and treatment of hepatorenal syndrome-AKI and refractory ascites, and equally whether the candidate can hold an honest prognostic and goals-of-care conversation with a stigmatised patient in a culture where end-of-life discussion is often avoided.

Show the answer outline

Knowledge: The pattern of a progressive rise in creatinine over days with a bland sediment, low urinary sodium, no shock, no nephrotoxins and no response to diuretic withdrawal is characteristic of hepatorenal syndrome-AKI by the International Club of Ascites criteria, but the diagnosis requires exclusion of hypovolaemia through albumin volume expansion at 1 g/kg per day for two days, exclusion of structural kidney disease, and exclusion of spontaneous bacterial peritonitis, which his neutrophil count of 90 does not meet since the threshold is 250 per mm3.

Management: I would stop diuretics, beta-blockers if hypotensive, and any nephrotoxins, give intravenous albumin 1 g/kg per day up to 100 g for two days as a volume challenge, send blood and ascitic cultures, repeat diagnostic paracentesis and screen for infection which is the commonest precipitant.

Ethics and communication: He has asked directly whether he is dying, and I must answer honestly, at his pace, checking first what he already understands and what he wants to know, and then giving a truthful and gentle picture that his liver disease is now advanced, that transplantation is currently not available to him, and that his remaining time is likely to be short.

Likely panel follow-up questions

  • Give the current International Club of Ascites diagnostic criteria for hepatorenal syndrome-AKI.
  • How do you distinguish hepatorenal syndrome from acute tubular necrosis at the bedside?
  • When would you offer renal replacement therapy in this patient, and when would you not?

Pitfalls in this case

  • Diagnosing hepatorenal syndrome without an albumin volume challenge and exclusion of infection and structural causes
  • Offering TIPS or dialysis without acknowledging futility and the absence of a transplant path
  • Avoiding the prognosis question or giving false hope of transplantation

Reference: EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, Journal of Hepatology 2018; AASLD Practice Guidance: Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome, Hepatology 2021

Biliary Disease and ERCP

An 80-year-old woman with atrial fibrillation on apixaban 5 mg twice daily and an eGFR of 38 mL/min presents with rigors, jaundice and right upper quadrant pain. She is hypotensive at 84/50 mmHg despite two litres of fluid, lactate 4.2 mmol/L, bilirubin 190 micromol/L, white cell count 21, platelets 88, and ultrasound shows a dilated common bile duct with stones. Her last apixaban dose was six hours ago. The anaesthetist is uneasy about sedating her and the ERCP list is fully booked tomorrow. What do you do?

What the panel is testing: This tests recognition and grading of severe acute cholangitis, the willingness to decompress the biliary tree urgently rather than wait for coagulation to normalise, safe periprocedural anticoagulation reasoning, and a plan B when cannulation fails or the list is unavailable.

Show the answer outline

Knowledge: This is Grade III, severe acute cholangitis by the Tokyo Guidelines 2018, because she has organ dysfunction with hypotension unresponsive to fluids and a raised lactate, and she also meets Charcot and arguably Reynolds criteria. Mortality in this group is high and the single determinant of outcome is the timeliness of biliary decompression, which should occur urgently and within twenty-four hours, and effectively as soon as she is resuscitated.

Management: Immediate sepsis management with blood cultures, broad-spectrum antibiotics covering Gram-negative and anaerobic biliary organisms according to local resistance patterns, fluid resuscitation and early vasopressor support with intensive care involvement rather than persisting with fluid alone. I would hold apixaban, check a full blood count, renal function and fibrinogen, and correct any coagulopathy from sepsis rather than reversing the DOAC pharmacologically.

Ethics and communication: Consent in a septic, hypotensive elderly patient requires a careful capacity assessment; if she retains capacity I must give her a genuine choice including the option of a less invasive percutaneous route, and if she does not, I would act in her best interests, consult next of kin and document who was involved and why.

Likely panel follow-up questions

  • Give the Tokyo Guidelines 2018 severity grading and the timing of drainage each grade requires.
  • Would you reverse apixaban here, and with what, and why or why not?
  • How do you manage a failed cannulation in a septic patient? What are your rescue techniques?

Pitfalls in this case

  • Delaying decompression until coagulation is normalised or until the next elective list
  • Performing sphincterotomy on therapeutic apixaban when a stent alone would decompress safely
  • Choosing conscious sedation in a septic, hypotensive octogenarian

Reference: Tokyo Guidelines 2018 for acute cholangitis and cholecystitis, Journal of Hepato-Biliary-Pancreatic Sciences 2018; ESGE Guideline: Endoscopy in patients on antiplatelet or anticoagulant therapy (update), Endoscopy 2021

Pancreatic Disease and Therapeutic Endoscopy

A 48-year-old man is four weeks into an admission with severe gallstone necrotising pancreatitis. He was improving but now has a temperature of 38.9 C, rising CRP and white cell count, and new confusion. Contrast CT shows a 12 cm walled-off necrotic collection in the lesser sac containing gas, with a small pseudoaneurysm arising from the splenic artery adjacent to the collection. He is in a hospital where endoscopic ultrasound is available but the interventional radiology service is off site at weekends. How would you proceed?

What the panel is testing: This tests the step-up approach to infected pancreatic necrosis, correct sequencing when a pseudoaneurysm coexists with a collection needing drainage, and realistic resource and escalation planning including transfer decisions. The panel is looking for procedural judgement and safe timing rather than heroics.

Show the answer outline

Knowledge: The clinical picture of late sepsis with gas within a walled-off necrotic collection is highly suggestive of infected necrosis, which occurs in around a third of patients with necrotising pancreatitis and is the main driver of late mortality. Routine prophylactic antibiotics have no role in sterile necrosis, but here targeted therapy is justified, and I would not routinely perform fine-needle aspiration for culture as it adds little and risks contamination.

Management: I would resuscitate with fluids, take blood cultures, start broad-spectrum antibiotics with good pancreatic penetration such as a carbapenem or piperacillin-tazobactam guided by local antibiograms, and involve intensive care given the confusion and organ dysfunction.

Ethics and communication: Consent for EUS-guided drainage must be specific and documented: I would explain the real risks of bleeding, perforation, stent migration and the likely need for repeated procedures, and I would be explicit that the pseudoaneurysm raises bleeding risk, because a generic endoscopy consent form would not withstand scrutiny.

Likely panel follow-up questions

  • Why should the pseudoaneurysm be embolised before drainage, and what would you do if he bleeds during endoscopy?
  • When would you choose percutaneous rather than endoscopic drainage?
  • What is disconnected pancreatic duct syndrome and how does it change your stent strategy?

Pitfalls in this case

  • Proceeding to drainage or necrosectomy without addressing the splenic artery pseudoaneurysm
  • Intervening too early, before the collection is walled off
  • Reflex open surgical necrosectomy rather than a step-up approach

Reference: ESGE Guideline: Endoscopic management of acute necrotizing pancreatitis, Endoscopy 2018; American Gastroenterological Association Clinical Practice Update on Management of Pancreatic Necrosis, Gastroenterology 2020

Acute Liver Failure, Capacity and Transplant Ethics

A 34-year-old woman is admitted thirty-six hours after ingesting an estimated 30 g of paracetamol with clear suicidal intent following a relationship breakdown. She has grade II encephalopathy, INR 4.8, ALT 6800 U/L, arterial pH 7.28, lactate 4.5 mmol/L and creatinine 210 micromol/L. She is receiving N-acetylcysteine. She has told the nurse that she does not want a transplant and wishes to be allowed to die. Her parents are at the bedside demanding that everything be done. How do you manage her?

What the panel is testing: This case tests the King's College criteria and acute liver failure management alongside the far harder issue of assessing capacity in an encephalopathic patient with a recent suicide attempt, and handling a conflict between a stated refusal and family insistence. The panel wants principled reasoning, not a rule quoted from memory.

Show the answer outline

Knowledge: This is paracetamol-induced acute liver failure with hyperacute onset, and she already fulfils the King's College criteria for paracetamol toxicity: an arterial pH below 7.30 after adequate resuscitation is sufficient alone, and she additionally has the triad of INR above 6.5, or in modified terms a markedly raised INR, creatinine above 300 micromol/L and grade III to IV encephalopathy is the alternative combination.

Management: Continue the N-acetylcysteine infusion without interruption and do not stop it because time has elapsed since ingestion, as late administration still improves outcomes in established hepatotoxicity. I would transfer her immediately to intensive care and telephone the regional liver transplant unit at once rather than waiting for grade III encephalopathy, because the window for transfer closes rapidly.

Ethics and communication: The first ethical task is a structured capacity assessment, documented in the notes, showing that encephalopathy prevents her from understanding, retaining and weighing the decision, which means her refusal is not a valid contemporaneous refusal and I must act in her best interests.

Likely panel follow-up questions

  • State the King's College criteria for paracetamol and for non-paracetamol acute liver failure.
  • How do you assess capacity in a patient with grade II encephalopathy, and what would change your answer?
  • Should a suicide attempt influence transplant listing? Justify your position.

Pitfalls in this case

  • Treating the encephalopathic patient's statement as a valid competent refusal and withdrawing active treatment
  • Treating the parents as the decision-makers and doing whatever they demand
  • Delaying contact with the transplant centre until grade III or IV encephalopathy

Reference: AASLD Practice Guidance on Acute Liver Failure, Hepatology 2023; EASL Clinical Practice Guidelines on the management of acute (fulminant) liver failure, Journal of Hepatology 2017

Common reasons candidates fail the Gastroenterology oral

  • ✕Suggesting that transfusion becomes permissible once the patient loses consciousness
  • ✕Being reassured by a normal ALT and a low HBV DNA level
  • ✕Continuing to insufflate air and dissect after recognising the perforation
  • ✕Doing nothing, or settling for an informal word because the colleague is senior and popular
  • ✕Dismissing the fasting request or telling her that religion cannot come into medical decisions
  • ✕Failing to apply objective day-three criteria and drifting on steroids into the second week

Gastroenterology oral syllabus

The clinical and professional areas the scenarios in this pack are drawn from:

  • Acute Liver Failure, Capacity and Transplant Ethics
  • Biliary Disease and ERCP
  • Colleague Performance, Quality Assurance and Governance
  • Consent, Refusal of Treatment and Emergency Haemorrhage
  • Cultural and Religious Considerations in Endoscopy Practice
  • Decompensated Cirrhosis, Hepatorenal Syndrome and End-of-Life Care
  • Endoscopic Complications, Disclosure of Error and Patient Safety
  • Endoscopy Unit Systems, Infection Control and Duty of Candour
  • Gastrointestinal Bleeding / Portal Hypertension
  • Inflammatory Bowel Disease
  • Pancreatic Disease and Therapeutic Endoscopy
  • Pancreatic Malignancy, Truth-telling and Consent
  • Small Bowel Disease and Diagnostic Reasoning
  • Viral Hepatitis and Interprofessional Practice

Panels expect specialist-level command of the written Gastroenterology blueprint too, which covers:

  • Oesophageal Diseases
  • Gastric and Duodenal Diseases and Helicobacter pylori
  • Gastrointestinal Bleeding
  • Pancreatic Diseases
  • Biliary Tract and Gallbladder Disease
  • Chronic Liver Disease, Cirrhosis and Portal Hypertension
  • Viral Hepatitis, Acute Liver Injury and Transplantation
  • Inflammatory Bowel Disease
  • Small and Large Intestine Disorders (non-IBD)
  • Gastrointestinal and Hepatobiliary Malignancies
  • GI Motility, Functional GI Disorders and Nutrition
  • Endoscopy Practice, Sedation and Procedural Complications (Miscellaneous)
  • Patient Safety, Professionalism, Ethics and Evidence-Based Practice

Sitting the written exam as well? Gastroenterology question bank or the free Gastroenterology mock exam.

Last reviewed September 2026

About these questions: every scenario and model answer is original, written for this pack, with a guideline or trial reference. No recalled or leaked exam content is used. How we write our questions.

Frequently asked questions

Are these real Consultant Gastroenterology - Oral Assessment exam questions?
No. Every item is original, researched by Neelim's exam research team against the exam blueprint published by the health authorities. Real, recalled or leaked exam content breaches the testing bodies' rules and can lead to a permanent exam ban - we do not sell it, and neither should anyone else.
How is the oral assessment actually run?
It varies by authority. DHA requires not less than five clinical scenarios across roughly 20-30 minutes with a minimum of two panellists, scored pass or fail. DOH Abu Dhabi runs 5-6 scenarios including an ethical case over 45-60 minutes on Microsoft Teams. SCFHS uses a structured consultant interview of two roughly 30-minute case-based sessions, and OMSB requires a viva for every candidate after the written exam. The pack briefs you on each.
Does this cover DHA, DOH, MOHAP and SCFHS?
The core clinical knowledge is shared across the GCC; what differs by regulator is the test vendor (Prometric for DHA, SCFHS, QCHP, NHRA, Kuwait MOH; Pearson VUE for DOH, OMSB), the format, the pass mark and the local-regulation slice. The pack briefs you on how each authority runs its panel.
How do I receive it?
As PDF files. Card checkout is being set up, so for now you request it from this page and we send it to you directly, usually the same day.

Still unsure whether you even need this exam?

Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.